All In MedTech

Company

Calyxo

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$141M

4 Form D offerings, 2022 to 2026

Equity

$141M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $40.1M raised of $40.1M sought, first sale Apr 1, 2026, 12 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Apr 1, 2026Equity$40.1M$40.1M12Rule 506(b)Form D ↗Apr 16, 2026

3 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Calyxo, Inc.
Headquarters
Pleasanton, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    8 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Calyxo.

    Latest FDA decisions

    Search the Clearance Tracker

    3 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT07155005 · 1,000 participants (planned) · Start Oct 12, 2026 · Primary completion Dec 2028

      Device: CVAC® SYSTEM; FLEXIBLE AND NAVIGATIONAL URETERAL ACCESS SHEATH (FANS) IN FLEXIBLE URETEROSCOPY (FURS) and 1 more · For: Urolithiasis; Stones, Kidney; Renal Stones and 1 more

      Sites: Miami, Florida; Wichita, Kansas; Cheektowaga, New York · 10 sites in all

    4 more trials with a free account

    Reports received

    54

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    26

    48% of reports

    Injury reports

    26

    48% of reports

    Death reports

    2

    3.7% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230000
    Jan 240000
    Feb 240000
    Mar 240000
    Apr 240000
    May 240000
    Jun 240000
    Jul 240000
    Aug 240000
    Sep 240000
    Oct 240001
    Nov 240010
    Dec 240010
    Jan 250000
    Feb 250220
    Mar 251100
    Apr 250400
    May 250500
    Jun 250200
    Jul 254000
    Aug 251000
    Sep 252100
    Oct 252300
    Nov 251000
    Dec 252400
    Jan 262200
    Feb 262400
    Mar 260000
    Apr 265100
    May 261220
    Jun 261200
    Jul 262200
    Aug 261300
    Sep 266200
    Oct 263400
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    The full in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    The full in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.